Evaluating the effects of Quebec's private-public drug insurance system.
作者信息
Morgan Steven G, Gagnon Marc-André, Charbonneau Mathieu, Vadeboncoeur Alain
机构信息
School of Population and Public Health (Morgan), University of British Columbia, Vancouver, BC; School of Public Policy and Administration (Gagnon), Carleton University, Ottawa, Ont.; Karl Polanyi Institute of Political Economy (Charbonneau), Concordia University; Family and Emergency Medicine Department (Vadeboncoeur), Montreal University, Montréal, Que.
出版信息
CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726.
Abstract
摘要
相似文献
1
Evaluating the effects of Quebec's private-public drug insurance system.评估魁北克公私合营药品保险制度的效果。
CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726.
2
Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.处方药覆盖的公私合作伙伴关系：魁北克全民药物保险计划的政策制定与成果，并与美国医疗保险处方药计划进行比较。
Milbank Q. 2007 Sep;85(3):469-98. doi: 10.1111/j.1468-0009.2007.00496.x.
3
Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.制药公司的财源。魁北克省的公共药品计划为生物技术热潮买单。
Can Fam Physician. 2002 Apr;48:831, 833, 836-8.
4
Quebec's proposed wait time guarantees.魁北克提出的等待时间保障措施。
CMAJ. 2006 Apr 11;174(8):1075-6. doi: 10.1503/cmaj.060332.
5
Prescription drug benefits for seniors and public/private collaboration.老年人的处方药福利与公私合作。
Beginnings. 2002 May-Jun;22(3):11.
6
Public stewardship of mixed health systems.混合卫生系统的公共管理
Lancet. 2009 Nov 7;374(9701):1577-8. doi: 10.1016/S0140-6736(09)61241-1. Epub 2009 Aug 11.
7
Taking our medicine: who should pay for what?
Healthc Pap. 2004;4(3):27-8; discussion 68-72. doi: 10.12927/hcpap..16873.
8
Lament for a health care system.对医疗保健系统的挽歌。
CMAJ. 2005 Jul 19;173(2):117, 119. doi: 10.1503/cmaj.050772.
9
The Drug Utilization Review Network of Quebec.魁北克药物利用审查网络。
Healthc Manage Forum. 1996 Summer;9(2):44-7. doi: 10.1016/S0840-4704(10)60852-6.
10
Drug coverage insurance as a novel element of private health insurance in Poland.药品覆盖保险作为波兰私人医疗保险的一个新元素。
Acta Pol Pharm. 2013 Jul-Aug;70(4):763-7.
引用本文的文献
1
Characteristics of persons with multiple sclerosis covered by public drug insurance in a Quebec Birth Cohort.魁北克出生队列中纳入公共药物保险的多发性硬化症患者的特征。
Prev Med Rep. 2025 Apr 30;54:103093. doi: 10.1016/j.pmedr.2025.103093. eCollection 2025 Jun.
2
The impact of prescription drug insurance on cost related non-adherence to medications in Canada: A Heckman sample selection approach.加拿大处方药保险对与费用相关的药物不依从性的影响：Heckman 样本选择方法。
PLoS One. 2023 Aug 9;18(8):e0289776. doi: 10.1371/journal.pone.0289776. eCollection 2023.
3
Emergency contraception subsidy in Canada: a comparative policy analysis.加拿大的紧急避孕补贴：比较政策分析。
BMC Health Serv Res. 2022 Sep 1;22(1):1110. doi: 10.1186/s12913-022-08416-1.
4
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策：规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
5
Inequity in insurance coverage for prescription drugs in New Brunswick, Canada.加拿大新不伦瑞克省处方药保险覆盖范围的不公平现象。
Can J Public Health. 2022 Aug;113(4):504-518. doi: 10.17269/s41997-022-00639-3. Epub 2022 Apr 29.
6
Not All Canadian Cancer Patients Are Equal-Disparities in Public Cancer Drug Funding across Canada.并非所有加拿大癌症患者都平等——加拿大各地公共癌症药物资金的差异。
Curr Oncol. 2022 Mar 17;29(3):2064-2072. doi: 10.3390/curroncol29030166.
7
A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.系统综述 umbrella review 处方药保险与费用分担与药物使用、卫生服务使用和健康的关联。
BMC Health Serv Res. 2022 Mar 3;22(1):297. doi: 10.1186/s12913-022-07554-w.
8
It's Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada".是时候彻底消灭僵尸了——评《加拿大全民医保》一文
Int J Health Policy Manag. 2020 Dec 1;9(12):528-530. doi: 10.15171/ijhpm.2020.03.
9
Election 2019: unprecedented hope for universal pharmacare.2019年大选：全民医保带来前所未有的希望。
CMAJ. 2019 Oct 15;191(41):E1116-E1117. doi: 10.1503/cmaj.191291.
10
How to pay for national pharmacare.如何为国家药物保险付费。
CMAJ. 2018 Nov 26;190(47):E1384-E1388. doi: 10.1503/cmaj.180897.
本文引用的文献
1
Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.10 个全民覆盖的高收入国家初级保健处方药支出的驱动因素。
CMAJ. 2017 Jun 12;189(23):E794-E799. doi: 10.1503/cmaj.161481.
2
Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey.2014年加拿大老年人中与费用相关的药物治疗不依从情况：一项电话调查的横断面分析
CMAJ Open. 2017 Jan 17;5(1):E40-E44. doi: 10.9778/cmajo.20160126. eCollection 2017 Jan-Mar.
3
Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.老年人因费用相关而不遵医嘱用药的情况：11 个发达国家调查的横断面分析。
BMJ Open. 2017 Jan 31;7(1):e014287. doi: 10.1136/bmjopen-2016-014287.
4
Mandatory universal drug plan, access to health care and health: Evidence from Canada.强制性全民药物计划、医疗保健可及性与健康：来自加拿大的证据
J Health Econ. 2015 Dec;44:80-96. doi: 10.1016/j.jhealeco.2015.08.004. Epub 2015 Aug 19.
5
Estimated cost of universal public coverage of prescription drugs in Canada.加拿大全民公共处方药保险的估计成本。
CMAJ. 2015 Apr 21;187(7):491-497. doi: 10.1503/cmaj.141564. Epub 2015 Mar 16.
6
Canadian pharmacare: looking back, looking forward.加拿大药物保险计划：回顾与展望。
Healthc Policy. 2012 Aug;8(1):14-23.
7
Toward higher-performance health systems: adults' health care experiences in seven countries, 2007.迈向更高绩效的卫生系统：2007年七个国家成年人的医疗保健经历
Health Aff (Millwood). 2007 Nov-Dec;26(6):w717-34. doi: 10.1377/hlthaff.26.6.w717.
8
Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.处方药覆盖的公私合作伙伴关系：魁北克全民药物保险计划的政策制定与成果，并与美国医疗保险处方药计划进行比较。
Milbank Q. 2007 Sep;85(3):469-98. doi: 10.1111/j.1468-0009.2007.00496.x.
9
Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance.一项费用分担型药物保险计划对接受社会救助者药物使用情况的影响。
Health Policy. 2003 May;64(2):163-72. doi: 10.1016/s0168-8510(02)00158-6.
10
Adverse events associated with prescription drug cost-sharing among poor and elderly persons.贫困和老年人群中与处方药费用分担相关的不良事件。
JAMA. 2001;285(4):421-9. doi: 10.1001/jama.285.4.421.
Zotero 插件